Zheng X - Search Results

1

The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.

Liu X, Fan Y, Liu Y, He X, Zheng X, Tan J, Jia Q, Meng Z. Liu X, et al. Among authors: zheng x. Updates Surg. 2020 Sep;72(3):871-884. doi: 10.1007/s13304-020-00773-y. Epub 2020 Apr 27. Updates Surg. 2020. PMID: 32342347

2

[Biological characteristics and management of familial papillary thyroid carcinoma].

Zhao J, Yu Y, Xia TT, Liu YZ, Wei SF, Zheng XQ, Gao M. Zhao J, et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Nov;46(11):897-900. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011. PMID: 22335974 Chinese.

3

BRAFV600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China.

Zheng X, Xia T, Lin L, Gao S, Lee Y, Yu Y, Wei S, Gao M. Zheng X, et al. World J Surg Oncol. 2012 Jun 8;10:104. doi: 10.1186/1477-7819-10-104. World J Surg Oncol. 2012. PMID: 22681706 Free PMC article.

4

Progression of solitary and multifocal papillary thyroid carcinoma - a retrospective study of 368 patients.

Zheng XQ, Wang C, Xu M, Yu Y, Yun XW, Jia YS, Wei SF, Ren XB, Gao M. Zheng XQ, et al. Chin Med J (Engl). 2012 Dec;125(24):4434-9. Chin Med J (Engl). 2012. PMID: 23253715

5

Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.

Zheng X, Wei S, Han Y, Li Y, Yu Y, Yun X, Ren X, Gao M. Zheng X, et al. Ann Surg Oncol. 2013 Jul;20(7):2266-73. doi: 10.1245/s10434-012-2851-z. Epub 2013 Jan 31. Ann Surg Oncol. 2013. PMID: 23370668

6

Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.

Zhi J, Zhao J, Gao M, Pan Y, Wu J, Li Y, Li D, Yu Y, Zheng X. Zhi J, et al. Among authors: zheng x. Int J Clin Oncol. 2018 Feb;23(1):59-65. doi: 10.1007/s10147-017-1170-6. Epub 2017 Jul 25. Int J Clin Oncol. 2018. PMID: 28744725 Free PMC article.

7

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower ¹³¹ i uptake in metastases.

Meng Z, Matsuse M, Saenko V, Yamashita S, Ren P, Zheng X, Jia Q, Tan J, Li N, Zheng W, Zhao L, Mitsutake N. Meng Z, et al. Among authors: zheng w, zheng x. IUBMB Life. 2019 Jul;71(7):1030-1040. doi: 10.1002/iub.2056. Epub 2019 Apr 26. IUBMB Life. 2019. PMID: 31026111 Free article.

8

Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.

Zhi J, Wu Y, Hu L, Zhao J, Liu H, Ruan X, Hou X, Zhang J, Zheng X, Gao M. Zhi J, et al. Among authors: zheng x. Int J Clin Oncol. 2020 Jan;25(1):59-66. doi: 10.1007/s10147-019-01522-x. Epub 2019 Aug 14. Int J Clin Oncol. 2020. PMID: 31414270

9

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway.

Meng X, Wang H, Zhao J, Hu L, Zhi J, Wei S, Ruan X, Hou X, Li D, Zhang J, Yang W, Qian B, Wu Y, Zhang Y, Meng Z, Guan L, Zhang H, Zheng X, Gao M. Meng X, et al. Among authors: zheng x. Front Oncol. 2020 Mar 11;10:217. doi: 10.3389/fonc.2020.00217. eCollection 2020. Front Oncol. 2020. PMID: 32219060 Free PMC article.

10

Tumor Biology is King: Secondary Tumors of the Thyroid From 2 Medical Centers in China.

Wu Y, Huang K, Zheng X, Gao M, Liu H. Wu Y, et al. Among authors: zheng x. Cancer Control. 2020 Jul-Aug;27(3):1073274820945984. doi: 10.1177/1073274820945984. Cancer Control. 2020. PMID: 32779493 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,114 results

Search Page

Filters